Preventing antimalarial drug resistance through combinations (Q39589995)

13 September 2017

Preventing antimalarial drug resistance through combinations (English)

1 reference

13 September 2017

0 references

1

White NJ

1 reference

13 September 2017

1 March 1998

1 reference

13 September 2017

Drug Resistance Updates

1 reference

13 September 2017

1

1 reference

13 September 2017

3-9

1 reference

13 September 2017

1

1 reference

Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Pyrimethamine resistant mutations in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

The mode of action and the mechanism of resistance to antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Current views on the population structure of plasmodium falciparum: Implications for control

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

The population dynamics of antimicrobial chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Effects of artemisinin derivatives on malaria transmissibility.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Combination treatment for falciparum prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

The prevention of antimalarial drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Mefloquine-resistant falciparum malaria on the Thai-Burmese border

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Antimalarial drug resistance: the pace quickens

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Predictors of treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

The effect of parasite populations on the curative action of pyrimethamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

The importance of parasite load in the killing of Plasmodium vinckei in mice treated with Corynebacterium parvum or alloxan monohydrate

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Early clinical failures after pyrimethamine-sulfadoxine treatment of uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2898%2980208-2

7 January 2021

10.1016/S1368-7646(98)80208-2

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

17092790